InvestorsHub Logo
Followers 47
Posts 4677
Boards Moderated 0
Alias Born 07/19/2006

Re: iwfal post# 3703

Friday, 03/07/2008 3:52:13 PM

Friday, March 07, 2008 3:52:13 PM

Post# of 8473
How can you be a mixed agonist/antagonist for the same receptor? In a key and lock analogy you are either blocking the lock - or picking the lock.


not so long ago this was the general sentiment - today we know the lock and key analogy is an oversimplification. there are multiple locks and keys, and often multiple modifiers (coactivaros/suppressors) that can act on a partiuclar lock and/or key, so that the net effect is a (often tissue-specific) unique response to a particular drug/hormone. the science is more fleshed out for estrogen than progesterone, so i suggest you read a good review (sorry don't have a reference handy) on SERMs to get an idea for the complexity of the system. note that the endometrium is comprised of not just one tissue type, but rather several distinct elements - glands, stroma, vasculature - so the effects on the endometrium may be distinct and unique depending on the profile of the drug
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RPRX News